Skip to main content

Jones James's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Sep 10, 2021

Accession no.
0001209191-21-055483
Filed
Sep 10, 2021
Trade date
Aug 2-31, 2021
Filing delay
39 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $2.63K. It was filed 39 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jones JamesCIK 0001490829Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 2, 2021Common StockPPurchaseAcquired+42$3.34+$140.2815,456Direct
Aug 3, 2021Common StockPPurchaseAcquired+42$3.17+$133.1415,498Direct
Aug 4, 2021Common StockPPurchaseAcquired+42$3.18+$133.5615,540Direct
Aug 5, 2021Common StockPPurchaseAcquired+42$3.11+$130.6215,582Direct
Aug 6, 2021Common StockPPurchaseAcquired+42$3.01+$126.4215,624Direct
Aug 9, 2021Common StockPPurchaseAcquired+42$2.93+$123.0615,666Direct
Aug 10, 2021Common StockPPurchaseAcquired+42$2.96+$124.3215,708Direct
Aug 11, 2021Common StockPPurchaseAcquired+42$2.98+$125.1615,750Direct
Aug 13, 2021Common StockPPurchaseAcquired+42$2.92+$122.6415,792Direct
Aug 16, 2021Common StockPPurchaseAcquired+42$2.92+$122.6415,834Direct
Aug 17, 2021Common StockPPurchaseAcquired+42$3.05+$128.115,876Direct
Aug 18, 2021Common StockPPurchaseAcquired+42$2.97+$124.7415,918Direct
Aug 19, 2021Common StockPPurchaseAcquired+42$3.02+$126.8415,960Direct
Aug 20, 2021Common StockPPurchaseAcquired+42$2.96+$124.3216,002Direct
Aug 23, 2021Common StockPPurchaseAcquired+42$2.87+$120.5416,044Direct
Aug 24, 2021Common StockPPurchaseAcquired+42$2.89+$121.3816,086Direct
Aug 25, 2021Common StockPPurchaseAcquired+42$2.79+$117.1816,128Direct
Aug 26, 2021Common StockPPurchaseAcquired+42$2.82+$118.4416,170Direct
Aug 27, 2021Common StockPPurchaseAcquired+42$2.84+$119.2816,212Direct
Aug 30, 2021Common StockPPurchaseAcquired+42$2.88+$120.9616,254Direct
Aug 31, 2021Common StockPPurchaseAcquired+42$2.93+$123.0616,296Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)